<SEC-DOCUMENT>0001493152-22-029269.txt : 20221021
<SEC-HEADER>0001493152-22-029269.hdr.sgml : 20221021
<ACCEPTANCE-DATETIME>20221021060355
ACCESSION NUMBER:		0001493152-22-029269
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221021
DATE AS OF CHANGE:		20221021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-250966
		FILM NUMBER:		221322133

	BUSINESS ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
Pursuant to Rule 424(b)(5)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
Statement No. 333-250966</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
                                            SUPPLEMENT</B></FONT></P>
                                                                     <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<B>to Prospectus dated December 4,
2020</B>)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 40%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0pt 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0pt 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form424b5_001.jpg" ALT="Microbot Medical" STYLE="height: 100px; width: 253px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement supplements and amends certain information contained in the prospectus supplement dated June 10, 2021 to the prospectus
dated December 4, 2020 (collectively, the &ldquo;June 2021 Prospectus&rdquo;), relating to the offer and sale of our common stock, par
value $0.01 per share (the &ldquo;Common Stock&rdquo;) through H.C. Wainwright &amp; Co., LLC (&ldquo;Wainwright&rdquo;), as sales agent,
in &ldquo;at the market offerings&rdquo; as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, pursuant to
the At the Market Offering Agreement with Wainwright dated as of June 10, 2021 (the &ldquo;ATM Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock is traded on The Nasdaq Capital Market under the symbol &ldquo;MBOT&rdquo;. The last sale price of the Common Stock on October
20, 2022 was $4.63 per share on The Nasdaq Capital Market. Under the June 2021 Prospectus, we initially registered up to
$10,000,000 of our Common Stock for offer and sale pursuant to the ATM Agreement. From June 10, 2021 through the date of this prospectus
supplement, we have not sold any shares of Common Stock under the June 2021 Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of this prospectus supplement is to suspend the ATM Agreement and to terminate the continuous offering by us under the June 2021
Prospectus effective on October 13, 2022. We will not make any sales of our Common Stock pursuant to the ATM Agreement unless and until
a new prospectus supplement is filed with the Securities and Exchange Commission; however, the ATM Agreement remains in full force
and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus supplement is October 21, 2022.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b5_001.jpg
<TEXT>
begin 644 form424b5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D /T# 2(  A$! Q$!_\0
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ML8EN+:4J/]_<5_F*\E8=5((/0BM$9'J_ASP/IMMIT,VHVZW-U*@9A)RJ9_A
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M,/YAW2VXX.[NR^N?2O1** /GZ:VN;63;/!+"X[.A4_K75?#ZQNSXC2[-M-Y
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M4;<.#W/I7:T@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
